Dublin, Oct. 09, 2020 (GLOBE NEWSWIRE) — The report has been added to ResearchAndMarkets.com’s offering.
The global CBD oil and CBD consumer health market size is expected to reach USD 123.2 billion by 2027, expanding at a CAGR of 25.6% over the forecast period.
Growing buyer awareness regarding various health benefits offered by cannabidiol (CBD) and increasing legalization of cannabidiol oil and infused products is contributing towards the adoption of cannabidiol as a consumer health product, thereby positively impacting the market growth. Furthermore, changing buyer perception and attitude towards hemp-derived cannabidiol-based products is further bolstering revenue growth over the forecast period.
Based on the type of product, the full spectrum oil segment dominated the market in 2019. Factors contributing to the increase in demand for cannabidiol include rising buyer preference toward cannabidiol as a product category, the surge in demand for full-spectrum distillates, and many companies entering into bulk as well as finished product business.
On the other hand, the nutraceuticals segment dominated the market with a share of 48.3% in 2019. Favorable government initiatives for hemp-derived cannabidiol, rising awareness regarding cannabidiol, and changing buyer preferences from chemical-based ingredients to organic ingredients in dietary supplements are the key factors driving the market.
In 2019, the B2B distribution channel segment accounted for the highest revenue share in the market. This growth is attributed to the increase in demand for cannabidiol oil in various sectors such as pharmaceutical, food and additives, health and wellness, and cosmetics. On the other hand, retail pharmacies dominated the market in 2019. The increase in the number of companies selling their products via retail pharmacies is fueling the growth of the segment.
North America dominated the market with a revenue share of 68.5% in 2019 owing to ease of accessibility, growing awareness regarding various medical benefits of cannabidiol among users, and the rise in the number of manufacturers.
CBD Oil & CBD Consumer Health Market Report Highlights
- The increasing legalization of cannabidiol based products and increasing adoption of cannabidiol as consumer products are anticipated to propel market growth.
- The cannabidiol oil segment dominated the market in 2019, owing to the surge in demand for full-spectrum products.
- Nutraceuticals dominated the market in 2019 with a share of 48.3%, owing to the rise in user shift from chemical-based ingredients to organic and herbal ingredients in dietary supplements.
- The B2B distribution channel segment dominated the market in 2019, owing to the increase in demand for cannabidiol based products in various sectors such as pharmaceutical, food and additives, health and wellness, and cosmetics.
- The retail pharmacies segment dominated the market with a revenue share of 40.7% in 2019, owing to exclusive collaborations of companies with retail pharmacies.
- North America dominated the market with a revenue share of 68.5% in 2019, owing to ease of accessibility, increase in awareness about cannabidiol, and legalization of medical cannabis in the region.
Key Topics Covered:
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Global CBD Oil Market Outlook, Estimates, Forecasts & Trend Analysis
3.1 CBD Oil Market: Variables, Trends & Scope
3.1.1 Market Segmentation (Global Cannabidiol (CBD) Consumer Health Market)
3.1.2 Penetration & Growth Prospect Mapping
3.1.3 Cannabis Regulatory Scenario, By Country
3.1.4 Market Dynamics
188.8.131.52 Market Driver Analysis
184.108.40.206.1 Growing legalization of cannabis-based CBD
220.127.116.11.2 Growing adoption of CBD-based products for treating various medical conditions
18.104.22.168.3 Growing number of companies producing Synthetic CBD for pharmaceutical applications
22.214.171.124 Market Restraint Analysis
126.96.36.199.1 Strict government regulations pertaining to production and distribution of CBD products
188.8.131.52 Industry Challenges
3.1.5 COVID-19 Impact Analysis (Current & Future)
3.1.6 CBD Oil- Porter’s Analysis
3.1.7 Cannabidiol (CBD)-PESTEL Analysis
3.1.8 Opportunity Analysis (2016-2020-2027)
3.1.9 Product Life Cycle Analysis, by Finished Product, By Country
3.1.10 Product Adoption Pattern Analysis
184.108.40.206 Full Spectrum CBD Oil
220.127.116.11 CBD Isolate
18.104.22.168 Synthetic CBD
3.1.11 Supply Chain Analysis
3.1.12 Market price evolution of biomass commodity cost (to processor/CBD manufacturer)
3.1.13 Manufacturing Trends/ Technology Adoptions Trends
3.1.14 Exhaustive list of Producers/Manufacturers by Country
3.2 Product Type Market Revenue Size, Forecasts and Trend Analysis, 2016 To 2027
3.2.1 CBD Oil Market: Product Type Analysis
22.214.171.124 Product Type Movement Analysis, Revenue (USD Million)
126.96.36.199 CBD Oil
188.8.131.52.1 Global CBD Oil market, 2016-2027 (USD Million)
184.108.40.206 CBD Isolate
220.127.116.11.1 Global CBD Isolate market, 2016-2027 (USD Million)
18.104.22.168 Synthetic CBD
22.214.171.124.1 Global synthetic CBD market, 2016-2027 (USD Million)
3.3 Distribution Channel Market Revenue Size, Forecasts and Trend Analysis, 2016 To 2027
3.4 CBD Oil Market: Distribution Channel Analysis
3.5 Distribution Channel Movement Analysis, Revenue (USD Million)
126.96.36.199 Global B2B market, 2016-2027 (USD Million)
188.8.131.52 Pharma Manufacturers
184.108.40.206.1 Global pharma manufacturers market, 2016-2027 (USD Million)
220.127.116.11 Consumer Goods Manufacturers
18.104.22.168.1 Global consumer goods manufacturers market, 2016-2027 (USD Million)
22.214.171.124 Nutraceutical Manufacturers
126.96.36.199.1 Global Nutraceutical manufacturers market, 2016-2027 (USD Million)
188.8.131.52.1 Global other manufacturers market, 2016-2027 (USD Million)
184.108.40.206 Global B2C market, 2016-2027 (USD Million)
Chapter 4 Global CBD Consumer Health Products Market Outlook, Estimates & Trend Analysis
4.1 CBD Consumer Health Products Market: Variables, Trends & Scope
4.1.1 Market Segmentation (Global Cannabidiol (CBD) Consumer Health Market)
4.1.2 Penetration & Growth Prospect Mapping
4.1.3 CBD Infused Products Regulatory Scenario, By Country
4.1.4 Market Dynamics
220.127.116.11 Market Driver Analysis
18.104.22.168.1 Cannabis revolution positively impacting consumer health market
22.214.171.124.2 Consumer perception and attitude toward CBD products
126.96.36.199.3 Rise in the number of retailers selling CBD-based products
188.8.131.52.4 Increasing demand for CBD nutraceuticals
184.108.40.206.5 Growing adoption of CBD topicals across the world
220.127.116.11.6 Rise in disposable income influencing CBD products demand
18.104.22.168 Market Restraint Analysis
22.214.171.124.1 Availability of alternatives to CBD supplements
126.96.36.199.2 High price of CBD products
188.8.131.52.3 Presence of counterfeit products
184.108.40.206 Industry Challenges
220.127.116.11.1 Uncertain government regulations related to CBD and CBD products
4.1.5 Covid-19 Impact Analysis
4.1.6 Cannabidiol (CBD) Consumer Health-Porter’s Analysis
4.1.7 Cannabidiol (CBD) Consumer Health-PESTEL Analysis
4.1.8 Opportunity Analysis (2016-2020-2027)
4.1.9 Product Adoption Pattern Analysis
18.104.22.168 CBD Medical Products
22.214.171.124 CBD Nutraceuticals
126.96.36.199 Personal Care & Cosmetics
4.1.10 Supply Chain Analysis (CBD Oil & CBD Consumer Health)
188.8.131.52 Supply Chain Analysis-CBD Consumer Health Product
184.108.40.206 Profit Margin Estimation
220.127.116.11 Case Study: Medical Marijuana, Inc.
18.104.22.168 Case Study: Isodiol International Inc.
22.214.171.124 Raw Material Trends
4.1.11 Market Price Evolution of Biomass Commodity Cost (To Processor/CBD Manufacturer)
4.1.12 Market Price Evolution (Raw Material to Finished Goods)
4.1.13 Manufacturing Trends/ Technology Adoptions Trends
4.1.14 Manufacturing Trends (Finished Goods)
4.1.15 Interdependency Analysis
4.1.16 Effects of Consolidation on the Value Chain
4.1.17 Exhaustive list of Producers/Manufacturers by Country
4.2 Product Type Market Revenue Size, Forecasts and Trend Analysis, 2016 To 2027
4.2.1 Cannabidiol (CBD) Consumer Products Market: Product Type Analysis
4.2.2 Product Type Movement Analysis, Revenue (USD Million)
126.96.36.199 Medical Products
188.8.131.52.1 Global OTC Medical Products market, 2016-2027 (USD Million)
184.108.40.206.2 CBD Analgesic Products
220.127.116.11.3 CBD Mental Health Products
18.104.22.168.4 CBD Dermatology Products
22.214.171.124.5 CBD Sleep Aids Products
126.96.36.199.6 Other OTC products
188.8.131.52.1 Global nutraceuticals market, 2016-2027 (USD Million)
184.108.40.206.2 CBD Vitamins and Dietary Supplements
220.127.116.11.3 CBD Sports Nutrition
18.104.22.168.4 CBD Weight Management and Wellbeing
22.214.171.124 Food & Beverages
126.96.36.199 Personal Care & Cosmetic Products
188.8.131.52.1 Global personal care & cosmetic products market, 2016-2027 (USD Million)
184.108.40.206.2 CBD Infused Skincare Products
220.127.116.11.3 CBD Infused Beauty Products
18.104.22.168.4 CBD Infused Haircare Products
4.3 Distribution Channel Market Revenue Size, Forecasts and Trend Analysis, 2016 To 2027
4.3.1 Cannabidiol (CBD) Consumer Products Market: Distribution Channel Analysis
4.3.2 Distribution Channel Movement Analysis, Revenue (USD Million)
22.214.171.124 Retail Stores
126.96.36.199 Retail Pharmacies
- CV Sciences, Inc.
- Medical Marijuana Inc.
- CHARLOTTE’S WEB
- NuLeaf Naturals, LLC
- JOY Organics
- Lord Jones
- Aurora Cannabis
- Canopy Growth Corporation
- Global Cannabinoids inc.
- cbd american shaman.
- BioVectra inc.
- Bluebird Botanicals
- cure pharmaceutical.
- GW Pharmaceuticals, plc.
- THC Pharm Gmbh
For more information about this report visit
Research and Markets also offers services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900